Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Auteur(s): Annenberg Center for Health Sciences
  • Résumé

  • In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
    Annenberg Center for Health Sciences
    Voir plus Voir moins
Épisodes
  • Cardiologist Collaboration
    Mar 5 2024
    • Role in Diabetes Management
    • Multidisciplinary Team-based Approach
    Voir plus Voir moins
    5 min
  • Individualizing Therapy
    Mar 5 2024
    • Drug Initiation and Monitoring
    • Contraindications and Adverse Effects
    • Patient Education
    Voir plus Voir moins
    8 min
  • Cardiovascular Benefits
    Mar 5 2024
    • FDA Indications
    • Clinical Trial Evidence

    Voir plus Voir moins
    4 min

Ce que les auditeurs disent de Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.